Cervus canadensis isolate Bull #8, Minnesota chromosome 30, ASM1932006v1, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Cervidae; Cervinae; Cervus.
A pseudomolecule assembly of the Rocky Mountain elk genome
REFSEQ INFORMATION: The reference sequence is identical to\nCM033220.1.\nAssembly name: ASM1932006v1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Iowa State University on\n2021/07/26. The original whole-genome shotgun project has the\naccession JACTMD000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Iowa State University\nAssembly Date :: 24-AUG-2020\nAssembly Method :: MaSuRCA v. MAY-2018\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 686.0x\nSequencing Technology :: PacBio RSII; Illumina HiSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Cervus canadensis Annotation Release\n 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 13% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122431991, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC122431991, transcript variant X1
COORDINATES: polyA evidence [ECO:0006239]
uncharacterized LOC122431991, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00015
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 75% coverage of the annotated genomic feature by RNAseq alignments
V-type proton ATPase subunit B, brain isoform
leucine zipper tumor suppressor 1, transcript variant X2
leucine zipper tumor suppressor 1, transcript variant X3
leucine zipper tumor suppressor 1, transcript variant X1
leucine zipper putative tumor suppressor 1
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glutamic acid (anticodon CUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
GDNF family receptor alpha 2, transcript variant X2
GDNF family receptor alpha 2, transcript variant X1
transfer RNA cysteine (anticodon GCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
nucleophosmin/nucleoplasmin 2, transcript variant X1
nucleophosmin/nucleoplasmin 2, transcript variant X2
nucleophosmin/nucleoplasmin 2, transcript variant X4
nucleophosmin/nucleoplasmin 2, transcript variant X3
fibroblast growth factor 17, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 13 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
fibroblast growth factor 17, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 10 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
dematin actin binding protein, transcript variant X1
dematin actin binding protein, transcript variant X3
dematin actin binding protein, transcript variant X2
dematin actin binding protein, transcript variant X5
dematin actin binding protein, transcript variant X4
dematin actin binding protein, transcript variant X7
dematin actin binding protein, transcript variant X6
dematin actin binding protein, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
FHF complex subunit HOOK interacting protein 2B, transcript variant X1
FHF complex subunit HOOK interacting protein 2B, transcript variant X2
FHF complex subunit HOOK interacting protein 2B, transcript variant X3
FHF complex subunit HOOK interacting protein 2B, transcript variant X4
FHF complex subunit HOOK interacting protein 2B isoform X1
FHF complex subunit HOOK interacting protein 2B isoform X2
FHF complex subunit HOOK interacting protein 2B isoform X3
HR lysine demethylase and nuclear receptor corepressor, transcript variant X2
lysine-specific demethylase hairless isoform X2
HR lysine demethylase and nuclear receptor corepressor, transcript variant X1
lysine-specific demethylase hairless isoform X1
HR upstream open reading frame, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
HR upstream open reading frame, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
receptor accessory protein 4, transcript variant X1
receptor accessory protein 4, transcript variant X2
receptor expression-enhancing protein 4 isoform X2
receptor expression-enhancing protein 4 isoform X1
pulmonary surfactant-associated protein C
bone morphogenetic protein 1, transcript variant X1
bone morphogenetic protein 1, transcript variant X2
phytanoyl-CoA 2-hydroxylase interacting protein, transcript variant X1
phytanoyl-CoA 2-hydroxylase interacting protein, transcript variant X2
phytanoyl-CoA hydroxylase-interacting protein
RNA polymerase III subunit D, transcript variant X1
RNA polymerase III subunit D, transcript variant X2
DNA-directed RNA polymerase III subunit RPC4
transfer RNA arginine (anticodon CCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
piwi like RNA-mediated gene silencing 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
piwi like RNA-mediated gene silencing 2, transcript variant X1
piwi like RNA-mediated gene silencing 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier family 39 member 14, transcript variant X2
solute carrier family 39 member 14, transcript variant X1
solute carrier family 39 member 14, transcript variant X3
protein phosphatase 3 catalytic subunit gamma, transcript variant X1
protein phosphatase 3 catalytic subunit gamma, transcript variant X3
protein phosphatase 3 catalytic subunit gamma, transcript variant X2
protein phosphatase 3 catalytic subunit gamma, transcript variant X4
serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X1
serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X3
serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X2
serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X4
sorbin and SH3 domain containing 3, transcript variant X1
sorbin and SH3 domain containing 3, transcript variant X5
sorbin and SH3 domain containing 3, transcript variant X2
sorbin and SH3 domain containing 3, transcript variant X6
sorbin and SH3 domain containing 3, transcript variant X3
sorbin and SH3 domain containing 3, transcript variant X8
sorbin and SH3 domain containing 3, transcript variant X4
sorbin and SH3 domain containing 3, transcript variant X7
sorbin and SH3 domain containing 3, transcript variant X9
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: PDZ and LIM domain protein 2
chromosome 30 C8orf58 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
chromosome 30 C8orf58 homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
chromosome 30 C8orf58 homolog, transcript variant X3
uncharacterized protein C8orf58 homolog isoform X1
uncharacterized protein C8orf58 homolog isoform X3
chromosome 30 C8orf58 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized protein C8orf58 homolog isoform X2
cell cycle and apoptosis regulator 2, transcript variant X3
cell cycle and apoptosis regulator 2, transcript variant X1
cell cycle and apoptosis regulator 2, transcript variant X4
cell cycle and apoptosis regulator 2, transcript variant X6
cell cycle and apoptosis regulator 2, transcript variant X5
cell cycle and apoptosis regulator 2, transcript variant X2
cell cycle and apoptosis regulator protein 2 isoform X3
cell cycle and apoptosis regulator protein 2 isoform X1
cell cycle and apoptosis regulator protein 2 isoform X4
cell cycle and apoptosis regulator protein 2 isoform X2
early growth response 3, transcript variant X1
early growth response 3, transcript variant X2
early growth response protein 3 isoform X1
early growth response protein 3 isoform X2
phosphatidylethanolamine binding protein 4, transcript variant X2
phosphatidylethanolamine binding protein 4, transcript variant X3
phosphatidylethanolamine binding protein 4, transcript variant X1
phosphatidylethanolamine-binding protein 4
rho-related BTB domain-containing protein 2
src substrate cortactin-like, transcript variant X2
src substrate cortactin-like, transcript variant X1
uncharacterized protein LOC122432092 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 94% coverage of the annotated genomic feature by RNAseq alignments
liprin-alpha-1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
liprin-alpha-1-like, transcript variant X1
liprin-alpha-1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
liprin-alpha-1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
src substrate cortactin-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
src substrate cortactin-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
src substrate cortactin-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
src substrate cortactin-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized protein LOC122432099 isoform X1
uncharacterized protein LOC122432099 isoform X2
src substrate cortactin-like, transcript variant X7
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X17
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X10
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X2
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X3
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X1
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X7
tumor necrosis factor receptor superfamily member 10A-like isoform X11
tumor necrosis factor receptor superfamily member 10A-like isoform X7
tumor necrosis factor receptor superfamily member 10A-like isoform X2
tumor necrosis factor receptor superfamily member 10C-like isoform X3
tumor necrosis factor receptor superfamily member 10A-like isoform X1
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X13
tumor necrosis factor receptor superfamily member 10C-like isoform X6
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X5
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X16
tumor necrosis factor receptor superfamily member 10B-like isoform X10
tumor necrosis factor receptor superfamily member 10B-like isoform X9
tumor necrosis factor receptor superfamily member 10C-like isoform X5
tumor necrosis factor receptor superfamily member 10C-like isoform X4
tumor necrosis factor receptor superfamily member 10A-like, transcript variant X12
tumor necrosis factor receptor superfamily member 10C-like isoform X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 69% coverage of the annotated genomic feature by RNAseq alignments
tumor necrosis factor receptor superfamily member 10C-like, transcript variant X3
tumor necrosis factor receptor superfamily member 10C-like, transcript variant X9
tumor necrosis factor receptor superfamily member 10A-like isoform X3
tumor necrosis factor receptor superfamily member 10A-like isoform X9
tumor necrosis factor receptor superfamily member 10C-like, transcript variant X2
tumor necrosis factor receptor superfamily member 10C-like, transcript variant X1
tumor necrosis factor receptor superfamily member 10C-like, transcript variant X5
tumor necrosis factor receptor superfamily member 10C-like, transcript variant X6
tumor necrosis factor receptor superfamily member 10C-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 10C-like, transcript variant X8
tumor necrosis factor receptor superfamily member 10C-like, transcript variant X10
tumor necrosis factor receptor superfamily member 10C-like, transcript variant X12
tumor necrosis factor receptor superfamily member 10C-like, transcript variant X11
tumor necrosis factor receptor superfamily member 10C-like, transcript variant X20
tumor necrosis factor receptor superfamily member 10C-like, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 10C-like, transcript variant X13
tumor necrosis factor receptor superfamily member 10C-like, transcript variant X19
tumor necrosis factor receptor superfamily member 10C-like, transcript variant X18
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 10C-like, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
tumor necrosis factor receptor superfamily member 10C-like, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 10C-like, transcript variant X17
tumor necrosis factor receptor superfamily member 10C-like, transcript variant X21
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 10C-like, transcript variant X22
tumor necrosis factor receptor superfamily member 10C-like, transcript variant X23
tumor necrosis factor receptor superfamily member 10C-like, transcript variant X24
tumor necrosis factor receptor superfamily member 10A-like isoform X5
tumor necrosis factor receptor superfamily member 10B-like isoform X8
tumor necrosis factor receptor superfamily member 10C-like isoform X10
tumor necrosis factor receptor superfamily member 10A-like isoform X6
tumor necrosis factor receptor superfamily member 10A-like isoform X13
tumor necrosis factor receptor superfamily member 10B-like isoform X4
tumor necrosis factor receptor superfamily member 10C-like isoform X12
tumor necrosis factor receptor superfamily member 10C-like isoform X14
tumor necrosis factor receptor superfamily member 10C-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized protein LOC122432096 isoform X3
uncharacterized protein LOC122432096 isoform X1
uncharacterized protein LOC122432096 isoform X2
tumor necrosis factor receptor superfamily member 10A-like isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 79% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
src substrate cortactin-like, transcript variant X8
src substrate cortactin-like, transcript variant X10
uncharacterized protein LOC122432093 isoform X8
uncharacterized protein LOC122432093 isoform X3
src substrate cortactin-like, transcript variant X9
uncharacterized protein LOC122432093 isoform X2
uncharacterized protein LOC122432093 isoform X1
uncharacterized protein LOC122432093 isoform X4
uncharacterized protein LOC122432093 isoform X7
uncharacterized protein LOC122432093 isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 73% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
uncharacterized protein LOC122432104 isoform X1
uncharacterized protein LOC122432104 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
R3H and coiled-coil domain-containing protein 1
small nucleolar RNA SNORA2/SNORA34 family
COORDINATES: nucleotide motif:Rfam:12.0:RF00410
transfer RNA glycine (anticodon UCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
ectonucleoside triphosphate diphosphohydrolase 4, transcript variant X4
ectonucleoside triphosphate diphosphohydrolase 4, transcript variant X3
ectonucleoside triphosphate diphosphohydrolase 4, transcript variant X5
ectonucleoside triphosphate diphosphohydrolase 4, transcript variant X1
ectonucleoside triphosphate diphosphohydrolase 4, transcript variant X2
ectonucleoside triphosphate diphosphohydrolase 4 isoform X2
ectonucleoside triphosphate diphosphohydrolase 4 isoform X1
solute carrier family 25 member 37, transcript variant X1
solute carrier family 25 member 37, transcript variant X2
solute carrier family 25 member 37, transcript variant X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
disintegrin and metalloproteinase domain-containing protein 28
COORDINATES: nucleotide motif:Rfam:12.0:RF00283
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 55% coverage of the annotated genomic feature by RNAseq alignments
disintegrin and metalloproteinase domain-containing protein 7
proline-rich protein 2-like, transcript variant X1
proline-rich protein 2-like, transcript variant X9
proline-rich protein 2-like, transcript variant X5
serine/arginine repetitive matrix protein 1-like isoform X1
proline-rich protein 2-like, transcript variant X6
proline-rich protein 2-like, transcript variant X8
proline-rich protein 2-like, transcript variant X4
proline-rich protein 2-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
proline-rich protein 2-like, transcript variant X10
proline-rich protein 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
proline-rich protein 2-like, transcript variant X11
proline-rich protein 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
serine/arginine repetitive matrix protein 1-like isoform X2
dedicator of cytokinesis 5, transcript variant X1
dedicator of cytokinesis 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
transfer RNA cysteine (anticodon ACA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
potassium channel tetramerization domain containing 9
cell division cycle-associated protein 2
protein phosphatase 2 regulatory subunit Balpha, transcript variant X3
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform isoform X3
protein phosphatase 2 regulatory subunit Balpha, transcript variant X2
protein phosphatase 2 regulatory subunit Balpha, transcript variant X1
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform isoform X1
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform isoform X2
protein phosphatase 2 regulatory subunit Balpha, transcript variant X4
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform isoform X4
BCL2 interacting protein 3 like, transcript variant X1
BCL2 interacting protein 3 like, transcript variant X2
BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like isoform X1
BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
adrenoceptor alpha 1A, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 1 EST, 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
adrenoceptor alpha 1A, transcript variant X7
adrenoceptor alpha 1A, transcript variant X6
adrenoceptor alpha 1A, transcript variant X10
adrenoceptor alpha 1A, transcript variant X8
adrenoceptor alpha 1A, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 mRNAs, 60 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
adrenoceptor alpha 1A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 mRNAs, 60 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
adrenoceptor alpha 1A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 mRNAs, 1 EST, 60 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
adrenoceptor alpha 1A, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 mRNAs, 60 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
adrenoceptor alpha 1A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 mRNAs, 60 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
adrenoceptor alpha 1A, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
transfer RNA glycine (anticodon CCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
adrenoceptor alpha 1A, transcript variant X12
adrenoceptor alpha 1A, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
epidermal growth factor receptor substrate 15-like 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 88% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
protein tyrosine kinase 2 beta, transcript variant X1
protein tyrosine kinase 2 beta, transcript variant X3
protein tyrosine kinase 2 beta, transcript variant X4
protein tyrosine kinase 2 beta, transcript variant X5
protein tyrosine kinase 2 beta, transcript variant X2
protein-tyrosine kinase 2-beta isoform X1
protein-tyrosine kinase 2-beta isoform X2
protein-tyrosine kinase 2-beta isoform X3
protein-tyrosine kinase 2-beta isoform X4
cholinergic receptor nicotinic alpha 2 subunit, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 2 ESTs, 25 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
cholinergic receptor nicotinic alpha 2 subunit, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 2 ESTs, 6 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
cholinergic receptor nicotinic alpha 2 subunit, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 ESTs, 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cholinergic receptor nicotinic alpha 2 subunit, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 ESTs, 4 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cholinergic receptor nicotinic alpha 2 subunit, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
neuronal acetylcholine receptor subunit alpha-2 isoform X1
neuronal acetylcholine receptor subunit alpha-2 isoform X2
neuronal acetylcholine receptor subunit alpha-2 isoform X3
neuronal acetylcholine receptor subunit alpha-2 isoform X4
neuronal acetylcholine receptor subunit alpha-2 isoform X5
L-gulonolactone oxidase, transcript variant X1
L-gulonolactone oxidase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 46% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 46% coverage of the annotated genomic feature by RNAseq alignments
DnaJ heat shock protein family (Hsp40) member A1
SMU1 DNA replication regulator and spliceosomal factor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC122431688, transcript variant X1
uncharacterized LOC122431688, transcript variant X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
BAG family molecular chaperone regulator 1
nuclear transcription factor, X-box binding 1, transcript variant X1
nuclear transcription factor, X-box binding 1, transcript variant X2
transcriptional repressor NF-X1 isoform X1
transcriptional repressor NF-X1 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 27 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
thiosulfate sulfurtransferase/rhodanese-like domain-containing protein 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00012
ubiquitin associated protein 2, transcript variant X2
ubiquitin associated protein 2, transcript variant X7
ubiquitin associated protein 2, transcript variant X6
ubiquitin associated protein 2, transcript variant X5
ubiquitin associated protein 2, transcript variant X4
ubiquitin associated protein 2, transcript variant X3
ubiquitin associated protein 2, transcript variant X1
ubiquitin associated protein 2, transcript variant X8
ubiquitin-associated protein 2 isoform X6
ubiquitin-associated protein 2 isoform X5
ubiquitin-associated protein 2 isoform X4
ubiquitin-associated protein 2 isoform X3
ubiquitin-associated protein 2 isoform X2
ubiquitin-associated protein 2 isoform X1
ubiquitin-associated protein 2 isoform X7
COORDINATES: nucleotide motif:Rfam:12.0:RF01191
transfer RNA tryptophan (anticodon CCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
ubiquitin associated protein 1, transcript variant X1
ubiquitin associated protein 1, transcript variant X4
ubiquitin associated protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
ubiquitin associated protein 1, transcript variant X3
ubiquitin-associated protein 1 isoform X1
ubiquitin-associated protein 1 isoform X2
kinesin family member 24, transcript variant X2
kinesin family member 24, transcript variant X3
kinesin family member 24, transcript variant X1
nudix hydrolase 2, transcript variant X2
nudix hydrolase 2, transcript variant X12
nudix hydrolase 2, transcript variant X10
nudix hydrolase 2, transcript variant X4
nudix hydrolase 2, transcript variant X9
nudix hydrolase 2, transcript variant X8
nudix hydrolase 2, transcript variant X1
nudix hydrolase 2, transcript variant X11
nudix hydrolase 2, transcript variant X5
nudix hydrolase 2, transcript variant X7
nudix hydrolase 2, transcript variant X6
nudix hydrolase 2, transcript variant X3
bis(5'-nucleosyl)-tetraphosphatase [asymmetrical]
myogenesis regulating glycosidase (putative)
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 2 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
spermatid-specific manchette-related protein 1
family with sequence similarity 219 member A, transcript variant X7
family with sequence similarity 219 member A, transcript variant X4
family with sequence similarity 219 member A, transcript variant X3
family with sequence similarity 219 member A, transcript variant X6
family with sequence similarity 219 member A, transcript variant X5
family with sequence similarity 219 member A, transcript variant X2
family with sequence similarity 219 member A, transcript variant X1
ciliary neurotrophic factor receptor, transcript variant X1
ciliary neurotrophic factor receptor, transcript variant X2
ciliary neurotrophic factor receptor, transcript variant X5
ciliary neurotrophic factor receptor, transcript variant X3
ciliary neurotrophic factor receptor, transcript variant X4
ciliary neurotrophic factor receptor subunit alpha isoform X1
ciliary neurotrophic factor receptor, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
ciliary neurotrophic factor receptor subunit alpha isoform X2
ribonuclease P/MRP subunit p25 like, transcript variant X2
ribonuclease P/MRP subunit p25 like, transcript variant X1
ribonuclease P/MRP subunit p25 like, transcript variant X3
ribonuclease P protein subunit p25-like protein
dynactin subunit 3, transcript variant X2
dynactin subunit 3, transcript variant X1
AT-rich interaction domain 3C, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
AT-rich interaction domain 3C, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
AT-rich interactive domain-containing protein 3C isoform X2
AT-rich interactive domain-containing protein 3C isoform X1
sigma non-opioid intracellular receptor 1, transcript variant X1
sigma non-opioid intracellular receptor 1, transcript variant X2
sigma non-opioid intracellular receptor 1 isoform X1
sigma non-opioid intracellular receptor 1 isoform X2
galactose-1-phosphate uridylyltransferase, transcript variant X2
galactose-1-phosphate uridylyltransferase, transcript variant X1
galactose-1-phosphate uridylyltransferase isoform X2
galactose-1-phosphate uridylyltransferase isoform X1
interleukin 11 receptor subunit alpha, transcript variant X2
interleukin 11 receptor subunit alpha, transcript variant X3
interleukin 11 receptor subunit alpha, transcript variant X1
interleukin-11 receptor subunit alpha isoform X2
interleukin-11 receptor subunit alpha isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
C-C motif chemokine ligand 19, transcript variant X2
C-C motif chemokine ligand 19, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 20% coverage of the annotated genomic feature by RNAseq alignments
protein FAM205A-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
protein FAM205A-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
protein FAM205A-like, transcript variant X3
RAS and EF-hand domain containing, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 8 ESTs, 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
RAS and EF-hand domain containing, transcript variant X2
ras and EF-hand domain-containing protein isoform X1
ras and EF-hand domain-containing protein isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: ras-related GTP-binding protein C-like
FERM domain containing 3, transcript variant X2
FERM domain-containing protein 3 isoform X2
FERM domain containing 3, transcript variant X1
FERM domain containing 3, transcript variant X3
FERM domain containing 3, transcript variant X4
FERM domain-containing protein 3 isoform X1
FERM domain-containing protein 3 isoform X3
FERM domain-containing protein 3 isoform X4
mRNA cap guanine-N7 methyltransferase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 4 ESTs, 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: mRNA cap guanine-N7 methyltransferase-like
IDNK gluconokinase, transcript variant X2
IDNK gluconokinase, transcript variant X5
IDNK gluconokinase, transcript variant X1
IDNK gluconokinase, transcript variant X4
IDNK gluconokinase, transcript variant X3
IDNK gluconokinase, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
G kinase anchoring protein 1, transcript variant X1
G kinase anchoring protein 1, transcript variant X2
kinesin family member 27, transcript variant X3
kinesin family member 27, transcript variant X10
kinesin family member 27, transcript variant X2
kinesin family member 27, transcript variant X9
kinesin family member 27, transcript variant X7
kinesin family member 27, transcript variant X5
kinesin family member 27, transcript variant X1
kinesin family member 27, transcript variant X6
kinesin family member 27, transcript variant X8
kinesin family member 27, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 ESTs, 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 70% coverage of the annotated genomic feature by RNAseq alignments
heterogeneous nuclear ribonucleoprotein K, transcript variant X3
heterogeneous nuclear ribonucleoprotein K, transcript variant X6
heterogeneous nuclear ribonucleoprotein K, transcript variant X5
heterogeneous nuclear ribonucleoprotein K, transcript variant X1
heterogeneous nuclear ribonucleoprotein K, transcript variant X7
heterogeneous nuclear ribonucleoprotein K, transcript variant X2
heterogeneous nuclear ribonucleoprotein K, transcript variant X4
heterogeneous nuclear ribonucleoprotein K isoform X4
heterogeneous nuclear ribonucleoprotein K isoform X2
heterogeneous nuclear ribonucleoprotein K isoform X3
heterogeneous nuclear ribonucleoprotein K isoform X1
RecQ mediated genome instability 1, transcript variant X1
RecQ mediated genome instability 1, transcript variant X2
recQ-mediated genome instability protein 1 isoform X2
recQ-mediated genome instability protein 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 14 ESTs, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
neurotrophic receptor tyrosine kinase 2, transcript variant X1
neurotrophic receptor tyrosine kinase 2, transcript variant X5
neurotrophic receptor tyrosine kinase 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 ESTs, 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
neurotrophic receptor tyrosine kinase 2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 ESTs, 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
neurotrophic receptor tyrosine kinase 2, transcript variant X9
neurotrophic receptor tyrosine kinase 2, transcript variant X2
neurotrophic receptor tyrosine kinase 2, transcript variant X4
neurotrophic receptor tyrosine kinase 2, transcript variant X3
BDNF/NT-3 growth factors receptor isoform X1
BDNF/NT-3 growth factors receptor isoform X2
BDNF/NT-3 growth factors receptor isoform X4
BDNF/NT-3 growth factors receptor isoform X5
BDNF/NT-3 growth factors receptor isoform X6
neurotrophic receptor tyrosine kinase 2, transcript variant X10
neurotrophic receptor tyrosine kinase 2, transcript variant X6
BDNF/NT-3 growth factors receptor isoform X3
BDNF/NT-3 growth factors receptor isoform X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins
ATP/GTP binding carboxypeptidase 1, transcript variant X1
ATP/GTP binding carboxypeptidase 1, transcript variant X2
ATP/GTP binding carboxypeptidase 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 16 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
N-alpha-acetyltransferase 35, NatC auxiliary subunit, transcript variant X1
N-alpha-acetyltransferase 35, NatC auxiliary subunit, transcript variant X2
N-alpha-acetyltransferase 35, NatC auxiliary subunit isoform X2
N-alpha-acetyltransferase 35, NatC auxiliary subunit, transcript variant X4
N-alpha-acetyltransferase 35, NatC auxiliary subunit, transcript variant X3
N-alpha-acetyltransferase 35, NatC auxiliary subunit isoform X1
N-alpha-acetyltransferase 35, NatC auxiliary subunit, transcript variant X5
N-alpha-acetyltransferase 35, NatC auxiliary subunit isoform X3
golgi membrane protein 1, transcript variant X4
golgi membrane protein 1, transcript variant X2
golgi membrane protein 1, transcript variant X1
golgi membrane protein 1, transcript variant X3
golgi membrane protein 1, transcript variant X5
iron-sulfur cluster assembly 1, transcript variant X1
iron-sulfur cluster assembly 1, transcript variant X2
iron-sulfur cluster assembly 1 homolog, mitochondrial isoform X1
iron-sulfur cluster assembly 1 homolog, mitochondrial isoform X2
terminal uridylyl transferase 7, transcript variant X6
terminal uridylyl transferase 7, transcript variant X7
terminal uridylyl transferase 7, transcript variant X4
terminal uridylyl transferase 7, transcript variant X1
terminal uridylyl transferase 7, transcript variant X2
terminal uridylyl transferase 7, transcript variant X5
terminal uridylyl transferase 7, transcript variant X3
terminal uridylyltransferase 7 isoform X3
terminal uridylyltransferase 7 isoform X2
terminal uridylyltransferase 7 isoform X1
terminal uridylyltransferase 7 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 60 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
yrdC domain-containing protein, mitochondrial-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: yrdC domain-containing protein, mitochondrial-like
uncharacterized LOC122431808, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122431808, transcript variant X3
uncharacterized LOC122431808, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC122431808, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC122431808, transcript variant X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00156
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 ESTs, 5 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 15 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
death associated protein kinase 1, transcript variant X6
death associated protein kinase 1, transcript variant X1
death associated protein kinase 1, transcript variant X4
death associated protein kinase 1, transcript variant X3
death associated protein kinase 1, transcript variant X2
death associated protein kinase 1, transcript variant X5
death-associated protein kinase 1 isoform X1
death associated protein kinase 1, transcript variant X7
death-associated protein kinase 1 isoform X2
aminopeptidase O (putative), transcript variant X10
aminopeptidase O (putative), transcript variant X13
aminopeptidase O (putative), transcript variant X14
aminopeptidase O (putative), transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
aminopeptidase O (putative), transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
aminopeptidase O (putative), transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
aminopeptidase O (putative), transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
aminopeptidase O (putative), transcript variant X4
aminopeptidase O (putative), transcript variant X9
aminopeptidase O (putative), transcript variant X11
aminopeptidase O (putative), transcript variant X12
aminopeptidase O (putative), transcript variant X1
aminopeptidase O (putative), transcript variant X7
aminopeptidase O (putative), transcript variant X6
aminopeptidase O (putative), transcript variant X3
aminopeptidase O (putative), transcript variant X8
aminopeptidase O (putative), transcript variant X2
FA complementation group C, transcript variant X6
FA complementation group C, transcript variant X1
FA complementation group C, transcript variant X3
FA complementation group C, transcript variant X4
FA complementation group C, transcript variant X2
FA complementation group C, transcript variant X5
FA complementation group C, transcript variant X7
Fanconi anemia group C protein isoform X2
Fanconi anemia group C protein isoform X1
Fanconi anemia group C protein isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 35% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122432120, transcript variant X1
uncharacterized LOC122432120, transcript variant X2
uncharacterized LOC122431946, transcript variant X2
uncharacterized LOC122431946, transcript variant X1
ERCC excision repair 6 like 2, transcript variant X2
ERCC excision repair 6 like 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ERCC excision repair 6 like 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
ERCC excision repair 6 like 2, transcript variant X1
DNA excision repair protein ERCC-6-like 2 isoform X4
DNA excision repair protein ERCC-6-like 2 isoform X5
DNA excision repair protein ERCC-6-like 2 isoform X1
DNA excision repair protein ERCC-6-like 2 isoform X2
ERCC excision repair 6 like 2, transcript variant X3
DNA excision repair protein ERCC-6-like 2 isoform X3
solute carrier family 35 member D2, transcript variant X3
solute carrier family 35 member D2, transcript variant X2
solute carrier family 35 member D2, transcript variant X1
solute carrier family 35 member D2, transcript variant X4
UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter isoform X2
UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter isoform X1
UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter isoform X4
UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter isoform X3
hyaluronan binding protein 4, transcript variant X1
hyaluronan binding protein 4, transcript variant X2
intracellular hyaluronan-binding protein 4 isoform X1
intracellular hyaluronan-binding protein 4 isoform X2
cell division cycle 14B, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
cell division cycle 14B, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
dual specificity protein phosphatase CDC14B isoform X15
dual specificity protein phosphatase CDC14B isoform X8
cell division cycle 14B, transcript variant X11
cell division cycle 14B, transcript variant X8
cell division cycle 14B, transcript variant X15
cell division cycle 14B, transcript variant X4
cell division cycle 14B, transcript variant X7
cell division cycle 14B, transcript variant X16
cell division cycle 14B, transcript variant X14
dual specificity protein phosphatase CDC14B isoform X13
dual specificity protein phosphatase CDC14B isoform X7
dual specificity protein phosphatase CDC14B isoform X4
dual specificity protein phosphatase CDC14B isoform X12
cell division cycle 14B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
cell division cycle 14B, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
cell division cycle 14B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
cell division cycle 14B, transcript variant X13
cell division cycle 14B, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cell division cycle 14B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
dual specificity protein phosphatase CDC14B isoform X5
dual specificity protein phosphatase CDC14B isoform X2
dual specificity protein phosphatase CDC14B isoform X1
dual specificity protein phosphatase CDC14B isoform X6
dual specificity protein phosphatase CDC14B isoform X3
dual specificity protein phosphatase CDC14B isoform X11
cell division cycle 14B, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
cell division cycle 14B, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
dual specificity protein phosphatase CDC14B isoform X9
dual specificity protein phosphatase CDC14B isoform X10
dual specificity protein phosphatase CDC14B isoform X14
peroxiredoxin like 2C, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
peroxiredoxin like 2C, transcript variant X3
peroxiredoxin like 2C, transcript variant X1
zinc finger protein 782, transcript variant X5
zinc finger protein 782, transcript variant X4
zinc finger protein 782, transcript variant X2
zinc finger protein 782, transcript variant X3
zinc finger protein 782, transcript variant X1
zinc finger protein 782, transcript variant X6
ubiquitin carboxyl-terminal hydrolase 14-like
family with sequence similarity 240 member B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
family with sequence similarity 240 member B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 20 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
zinc finger protein 484, transcript variant X3
zinc finger protein 484, transcript variant X1
zinc finger protein 484, transcript variant X4
zinc finger protein 484, transcript variant X6
zinc finger protein 484, transcript variant X7
zinc finger protein 484, transcript variant X2
zinc finger protein 484, transcript variant X5
eukaryotic translation initiation factor 2 subunit 3-like
isoleucyl-tRNA synthetase 1, transcript variant X2
isoleucyl-tRNA synthetase 1, transcript variant X1
isoleucyl-tRNA synthetase 1, transcript variant X3
isoleucine--tRNA ligase, cytoplasmic isoform X1
isoleucine--tRNA ligase, cytoplasmic isoform X2
isoleucine--tRNA ligase, cytoplasmic isoform X3
COORDINATES: nucleotide motif:Rfam:12.0:RF01229
nucleolar protein 8, transcript variant X3
nucleolar protein 8, transcript variant X2
nucleolar protein 8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
extracellular matrix protein 2, transcript variant X2
extracellular matrix protein 2, transcript variant X1
extracellular matrix protein 2 isoform X2
extracellular matrix protein 2 isoform X1
39S ribosomal protein L42, mitochondrial-like
inositol-pentakisphosphate 2-kinase, transcript variant X3
inositol-pentakisphosphate 2-kinase, transcript variant X1
inositol-pentakisphosphate 2-kinase isoform X3
inositol-pentakisphosphate 2-kinase isoform X1
inositol-pentakisphosphate 2-kinase, transcript variant X2
inositol-pentakisphosphate 2-kinase isoform X2
BICD cargo adaptor 2, transcript variant X1
BICD cargo adaptor 2, transcript variant X2
small nucleolar RNA SNORA42/SNORA80 family
COORDINATES: nucleotide motif:Rfam:12.0:RF00406
FYVE, RhoGEF and PH domain containing 3, transcript variant X4
FYVE, RhoGEF and PH domain containing 3, transcript variant X3
FYVE, RhoGEF and PH domain containing 3, transcript variant X2
FYVE, RhoGEF and PH domain containing 3, transcript variant X5
FYVE, RhoGEF and PH domain containing 3, transcript variant X1
FYVE, RhoGEF and PH domain-containing protein 3 isoform X1
FYVE, RhoGEF and PH domain-containing protein 3 isoform X3
FYVE, RhoGEF and PH domain-containing protein 3 isoform X2
uncharacterized LOC122431746, transcript variant X2
uncharacterized LOC122431746, transcript variant X1
caspase recruitment domain family member 19, transcript variant X2
caspase recruitment domain family member 19, transcript variant X1
caspase recruitment domain-containing protein 19 isoform X1
caspase recruitment domain-containing protein 19 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00443
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 mRNAs, 9 ESTs, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
WNK lysine deficient protein kinase 2, transcript variant X2
WNK lysine deficient protein kinase 2, transcript variant X4
WNK lysine deficient protein kinase 2, transcript variant X5
WNK lysine deficient protein kinase 2, transcript variant X6
WNK lysine deficient protein kinase 2, transcript variant X1
WNK lysine deficient protein kinase 2, transcript variant X3
serine/threonine-protein kinase WNK2 isoform X1
serine/threonine-protein kinase WNK2 isoform X2
serine/threonine-protein kinase WNK2 isoform X3
serine/threonine-protein kinase WNK2 isoform X4
serine/threonine-protein kinase WNK2 isoform X5
serine/threonine-protein kinase WNK2 isoform X6
constitutive coactivator of PPAR-gamma-like protein 1
PHD finger protein 2, transcript variant X2
PHD finger protein 2, transcript variant X1
lysine-specific demethylase PHF2 isoform X1
lysine-specific demethylase PHF2 isoform X2
PHD finger protein 2, transcript variant X3
lysine-specific demethylase PHF2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
protein tyrosine phosphatase domain containing 1, transcript variant X1
protein tyrosine phosphatase domain containing 1, transcript variant X2
protein tyrosine phosphatase domain-containing protein 1 isoform X1
protein tyrosine phosphatase domain containing 1, transcript variant X3
protein tyrosine phosphatase domain-containing protein 1 isoform X3
protein tyrosine phosphatase domain-containing protein 1 isoform X2
tripartite motif-containing protein 54-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 67% coverage of the annotated genomic feature by RNAseq alignments
zinc finger protein 169, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
zinc finger protein 169, transcript variant X4
zinc finger protein 169, transcript variant X5
zinc finger protein 169, transcript variant X2
zinc finger protein 169, transcript variant X8
zinc finger protein 169, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
zinc finger protein 169, transcript variant X7
zinc finger protein 169, transcript variant X1
zinc finger protein 169, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
serine/threonine-protein kinase MRCK alpha-like
serine palmitoyltransferase long chain base subunit 1
receptor tyrosine kinase like orphan receptor 2, transcript variant X2
tyrosine-protein kinase transmembrane receptor ROR2 isoform X2
receptor tyrosine kinase like orphan receptor 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
receptor tyrosine kinase like orphan receptor 2, transcript variant X1
tyrosine-protein kinase transmembrane receptor ROR2 isoform X1
tyrosine-protein kinase transmembrane receptor ROR2 isoform X3
nuclear factor interleukin-3-regulated protein
AU RNA binding methylglutaconyl-CoA hydratase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
AU RNA binding methylglutaconyl-CoA hydratase, transcript variant X4
AU RNA binding methylglutaconyl-CoA hydratase, transcript variant X1
AU RNA binding methylglutaconyl-CoA hydratase, transcript variant X3
methylglutaconyl-CoA hydratase, mitochondrial isoform X2
methylglutaconyl-CoA hydratase, mitochondrial isoform X1
methylglutaconyl-CoA hydratase, mitochondrial isoform X3
methylglutaconyl-CoA hydratase, mitochondrial isoform X4
spleen associated tyrosine kinase, transcript variant X3
spleen associated tyrosine kinase, transcript variant X1
spleen associated tyrosine kinase, transcript variant X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00548
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 30% coverage of the annotated genomic feature by RNAseq alignments
growth arrest and DNA damage inducible gamma
growth arrest and DNA damage-inducible protein GADD45 gamma
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00568
SECIS binding protein 2, transcript variant X9
SECIS binding protein 2, transcript variant X8
SECIS binding protein 2, transcript variant X1
SECIS binding protein 2, transcript variant X7
SECIS binding protein 2, transcript variant X5
SECIS binding protein 2, transcript variant X6
SECIS binding protein 2, transcript variant X4
SECIS binding protein 2, transcript variant X3
SECIS binding protein 2, transcript variant X2
selenocysteine insertion sequence-binding protein 2 isoform X7
selenocysteine insertion sequence-binding protein 2 isoform X5
selenocysteine insertion sequence-binding protein 2 isoform X9
selenocysteine insertion sequence-binding protein 2 isoform X6
selenocysteine insertion sequence-binding protein 2 isoform X8
selenocysteine insertion sequence-binding protein 2 isoform X4
selenocysteine insertion sequence-binding protein 2 isoform X3
selenocysteine insertion sequence-binding protein 2 isoform X2
selenocysteine insertion sequence-binding protein 2 isoform X1
CDC28 protein kinase regulatory subunit 2
cyclin-dependent kinases regulatory subunit 2
SHC adaptor protein 3, transcript variant X2
SHC adaptor protein 3, transcript variant X3
SHC adaptor protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 4% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins
nucleoredoxin like 2, transcript variant X4
nucleoredoxin like 2, transcript variant X2
nucleoredoxin like 2, transcript variant X1
nucleoredoxin like 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 54 Proteins
mitochondrial import inner membrane translocase subunit Tim29-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 79% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: mitochondrial import inner membrane translocase subunit Tim29-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cyclin dependent kinase 20, transcript variant X8
cyclin dependent kinase 20, transcript variant X9
cyclin dependent kinase 20, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
cyclin dependent kinase 20, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cyclin dependent kinase 20, transcript variant X5
cyclin dependent kinase 20, transcript variant X2
cyclin dependent kinase 20, transcript variant X1
cyclin dependent kinase 20, transcript variant X3
cyclin dependent kinase 20, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins
Myb/SANT DNA binding domain containing 3, transcript variant X3
Myb/SANT DNA binding domain containing 3, transcript variant X1
Myb/SANT DNA binding domain containing 3, transcript variant X2
myb/SANT-like DNA-binding domain-containing protein 3
transmembrane protein with EGF like and two follistatin like domains 1
phospholipid phosphatase related 1, transcript variant X2
phospholipid phosphatase related 1, transcript variant X1
uncharacterized LOC122431996, transcript variant X2
uncharacterized LOC122431996, transcript variant X1
phospholipid phosphatase-related protein type 1
acyl-coenzyme A amino acid N-acyltransferase 2-like, transcript variant X1
acyl-coenzyme A amino acid N-acyltransferase 2-like, transcript variant X2
acyl-coenzyme A amino acid N-acyltransferase 2-like
39S ribosomal protein L50, mitochondrial
zinc finger protein 189, transcript variant X1
zinc finger protein 189, transcript variant X2
zinc finger protein 189, transcript variant X4
zinc finger protein 189, transcript variant X3
post-GPI attachment to proteins GalNAc transferase 4, transcript variant X4
post-GPI attachment to proteins GalNAc transferase 4, transcript variant X2
post-GPI attachment to proteins GalNAc transferase 4, transcript variant X5
post-GPI attachment to proteins GalNAc transferase 4, transcript variant X7
post-GPI attachment to proteins GalNAc transferase 4, transcript variant X6
post-GPI attachment to proteins GalNAc transferase 4, transcript variant X3
post-GPI attachment to proteins GalNAc transferase 4, transcript variant X1
post-GPI attachment to proteins factor 4
uncharacterized LOC122431833, transcript variant X1
uncharacterized LOC122431833, transcript variant X5
uncharacterized LOC122431833, transcript variant X2
uncharacterized LOC122431833, transcript variant X3
uncharacterized LOC122431833, transcript variant X4
glutamate ionotropic receptor NMDA type subunit 3A
protein phosphatase 3 regulatory subunit B, beta
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 5 Proteins, and 44% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 48% coverage of the annotated genomic feature by RNAseq alignments
endogenous retrovirus group PABLB member 1 Env polyprotein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 86% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 43% coverage of the annotated genomic feature by RNAseq alignments
structural maintenance of chromosomes protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 10% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 68 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 72 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 38 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 mRNAs, 70 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 75 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 62 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 41 Proteins
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; deleted 1 base in 1 codon; substituted 3 bases at 3 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: olfactory receptor 13D1
protein NipSnap homolog 3A, transcript variant X2
protein NipSnap homolog 3A, transcript variant X1
ATP binding cassette subfamily A member 1, transcript variant X1
ATP binding cassette subfamily A member 1, transcript variant X6
ATP binding cassette subfamily A member 1, transcript variant X3
ATP binding cassette subfamily A member 1, transcript variant X5
ATP binding cassette subfamily A member 1, transcript variant X2
ATP binding cassette subfamily A member 1, transcript variant X7
ATP binding cassette subfamily A member 1, transcript variant X4
phospholipid-transporting ATPase ABCA1 isoform X1
phospholipid-transporting ATPase ABCA1 isoform X2
solute carrier family 44 member 1, transcript variant X3
solute carrier family 44 member 1, transcript variant X2
solute carrier family 44 member 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
choline transporter-like protein 1 isoform X3
choline transporter-like protein 1 isoform X2
choline transporter-like protein 1 isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: ubiquitin-conjugating enzyme E2 D3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
fibronectin type III and SPRY domain containing 1 like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
fibronectin type III and SPRY domain containing 1 like, transcript variant X1
fibronectin type III and SPRY domain containing 1 like, transcript variant X4
fibronectin type III and SPRY domain containing 1 like, transcript variant X2
fibronectin type III and SPRY domain containing 1 like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
T-cell acute lymphocytic leukemia protein 2
transmembrane protein 38B, transcript variant X1
transmembrane protein 38B, transcript variant X2
trimeric intracellular cation channel type B isoform X1
trimeric intracellular cation channel type B isoform X2
eukaryotic translation initiation factor 5A
eukaryotic translation initiation factor 5A-1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 mRNAs, 22 Proteins
zinc finger protein 462, transcript variant X2
zinc finger protein 462, transcript variant X4
zinc finger protein 462, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
zinc finger protein 462, transcript variant X8
zinc finger protein 462, transcript variant X10
zinc finger protein 462, transcript variant X1
zinc finger protein 462, transcript variant X11
zinc finger protein 462, transcript variant X13
zinc finger protein 462, transcript variant X3
zinc finger protein 462, transcript variant X6
zinc finger protein 462, transcript variant X9
zinc finger protein 462, transcript variant X7
zinc finger protein 462, transcript variant X5
mitochondrial import receptor subunit TOM40 homolog
RAD23 homolog B, nucleotide excision repair protein
UV excision repair protein RAD23 homolog B
transfer RNA histidin (anticodon GUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Kruppel like factor 4, transcript variant X2
Kruppel like factor 4, transcript variant X1
Kruppel like factor 4, transcript variant X3
uncharacterized LOC122431865, transcript variant X1
uncharacterized LOC122431865, transcript variant X2
uncharacterized LOC122431930, transcript variant X2
uncharacterized LOC122431930, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins
elongator acetyltransferase complex subunit 1
transmembrane protein 245, transcript variant X2
transmembrane protein 245, transcript variant X1
ferric chelate reductase 1 like, transcript variant X1
ferric chelate reductase 1 like, transcript variant X2
ferric chelate reductase 1 like, transcript variant X3
DOMON domain-containing protein FRRS1L isoform X1
DOMON domain-containing protein FRRS1L isoform X2
erythrocyte membrane protein band 4.1 like 4B, transcript variant X4
erythrocyte membrane protein band 4.1 like 4B, transcript variant X5
erythrocyte membrane protein band 4.1 like 4B, transcript variant X7
erythrocyte membrane protein band 4.1 like 4B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
erythrocyte membrane protein band 4.1 like 4B, transcript variant X3
erythrocyte membrane protein band 4.1 like 4B, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
erythrocyte membrane protein band 4.1 like 4B, transcript variant X1
ATP synthase subunit ATP5MJ, mitochondrial-like
erythrocyte membrane protein band 4.1 like 4B, transcript variant X8
protein tyrosine phosphatase non-receptor type 3, transcript variant X1
protein tyrosine phosphatase non-receptor type 3, transcript variant X2
protein tyrosine phosphatase non-receptor type 3, transcript variant X3
tyrosine-protein phosphatase non-receptor type 3 isoform X2
tyrosine-protein phosphatase non-receptor type 3 isoform X1
tyrosine-protein phosphatase non-receptor type 3 isoform X3
PALM2 and AKAP2 fusion, transcript variant X8
PALM2 and AKAP2 fusion, transcript variant X3
PALM2 and AKAP2 fusion, transcript variant X2
signal peptidase complex catalytic subunit SEC11A-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 3 ESTs, 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
PALM2 and AKAP2 fusion, transcript variant X4
PALM2 and AKAP2 fusion, transcript variant X1
PALM2 and AKAP2 fusion, transcript variant X7
PALM2 and AKAP2 fusion, transcript variant X6
PALM2 and AKAP2 fusion, transcript variant X5
uncharacterized protein C9orf152 homolog
thioredoxin domain containing 8, transcript variant X2
thioredoxin domain-containing protein 8 isoform X2
thioredoxin domain containing 8, transcript variant X1
thioredoxin domain-containing protein 8 isoform X1
sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1
muscle associated receptor tyrosine kinase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 ESTs, 3 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
muscle associated receptor tyrosine kinase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 ESTs, 3 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
muscle, skeletal receptor tyrosine-protein kinase isoform X1
muscle, skeletal receptor tyrosine-protein kinase isoform X2
lysophosphatidic acid receptor 1, transcript variant X1
lysophosphatidic acid receptor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 27 Proteins
Ecm29 proteasome adaptor and scaffold, transcript variant X2
Ecm29 proteasome adaptor and scaffold, transcript variant X4
Ecm29 proteasome adaptor and scaffold, transcript variant X1
Ecm29 proteasome adaptor and scaffold, transcript variant X3
proteasome adapter and scaffold protein ECM29 isoform X2
proteasome adapter and scaffold protein ECM29 isoform X1
proteasome adapter and scaffold protein ECM29 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 46% coverage of the annotated genomic feature by RNAseq alignments
DnaJ heat shock protein family (Hsp40) member C25
G protein subunit gamma 10, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 ESTs, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
G protein subunit gamma 10, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 ESTs, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 isoform X2
G protein subunit gamma 10, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 32% coverage of the annotated genomic feature by RNAseq alignments
protein shortage in chiasmata 1 ortholog
UDP-glucose ceramide glucosyltransferase
sushi domain containing 1, transcript variant X2
sushi domain-containing protein 1 isoform X2
sushi domain containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
sushi domain-containing protein 1 isoform X1
sushi domain containing 1, transcript variant X3
sushi domain-containing protein 1 isoform X3
uncharacterized LOC122431985, transcript variant X1
uncharacterized LOC122431985, transcript variant X2
polypyrimidine tract binding protein 3, transcript variant X2
polypyrimidine tract binding protein 3, transcript variant X1
polypyrimidine tract binding protein 3, transcript variant X4
polypyrimidine tract binding protein 3, transcript variant X5
polypyrimidine tract binding protein 3, transcript variant X3
polypyrimidine tract binding protein 3, transcript variant X6
polypyrimidine tract binding protein 3, transcript variant X7
polypyrimidine tract-binding protein 3 isoform X2
polypyrimidine tract-binding protein 3 isoform X1
polypyrimidine tract-binding protein 3 isoform X4
polypyrimidine tract-binding protein 3 isoform X3
polypyrimidine tract-binding protein 3 isoform X5
polypyrimidine tract-binding protein 3 isoform X7
polypyrimidine tract-binding protein 3 isoform X6
COORDINATES: nucleotide motif:Rfam:12.0:RF00020
hydroxysteroid dehydrogenase-like protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42% coverage of the annotated genomic feature by RNAseq alignments
KIAA1958 ortholog, transcript variant X10
KIAA1958 ortholog, transcript variant X7
KIAA1958 ortholog, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
KIAA1958 ortholog, transcript variant X9
KIAA1958 ortholog, transcript variant X2
KIAA1958 ortholog, transcript variant X1
KIAA1958 ortholog, transcript variant X3
KIAA1958 ortholog, transcript variant X4
KIAA1958 ortholog, transcript variant X5
KIAA1958 ortholog, transcript variant X6
uncharacterized protein KIAA1958 homolog isoform X5
uncharacterized protein KIAA1958 homolog isoform X2
uncharacterized protein KIAA1958 homolog isoform X3
uncharacterized protein KIAA1958 homolog isoform X4
uncharacterized protein KIAA1958 homolog isoform X1
sorting nexin family member 30, transcript variant X1
sorting nexin family member 30, transcript variant X2
ZFP37 zinc finger protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
zinc finger protein 37 homolog isoform X2
A-kinase anchor protein 10, mitochondrial-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: A-kinase anchor protein 10, mitochondrial-like
ZFP37 zinc finger protein, transcript variant X1
zinc finger protein 37 homolog isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 5 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
solute carrier family 31 member 2, transcript variant X2
solute carrier family 31 member 2, transcript variant X1
probable low affinity copper uptake protein 2 isoform X1
probable low affinity copper uptake protein 2 isoform X2
FKBP prolyl isomerase family member 15, transcript variant X5
FKBP prolyl isomerase family member 15, transcript variant X2
FKBP prolyl isomerase family member 15, transcript variant X4
FKBP prolyl isomerase family member 15, transcript variant X3
FKBP prolyl isomerase family member 15, transcript variant X1
FKBP prolyl isomerase family member 15, transcript variant X6
solute carrier family 31 member 1, transcript variant X1
solute carrier family 31 member 1, transcript variant X3
solute carrier family 31 member 1, transcript variant X2
solute carrier family 31 member 1, transcript variant X4
cell division cycle 26, transcript variant X1
cell division cycle 26, transcript variant X2
anaphase-promoting complex subunit CDC26 isoform X1
anaphase-promoting complex subunit CDC26 isoform X2
pre-mRNA processing factor 4, transcript variant X1
pre-mRNA processing factor 4, transcript variant X2
pre-mRNA processing factor 4, transcript variant X3
pre-mRNA processing factor 4, transcript variant X4
U4/U6 small nuclear ribonucleoprotein Prp4 isoform X1
U4/U6 small nuclear ribonucleoprotein Prp4 isoform X2
U4/U6 small nuclear ribonucleoprotein Prp4 isoform X3
U4/U6 small nuclear ribonucleoprotein Prp4 isoform X4
pre-mRNA processing factor 4, transcript variant X5
U4/U6 small nuclear ribonucleoprotein Prp4 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
ring finger protein 183, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 ESTs, 2 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ring finger protein 183, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
WD repeat domain 31, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
WD repeat domain 31, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
WD repeat domain 31, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
WD repeat-containing protein 31 isoform X2
WD repeat-containing protein 31 isoform X1
B-box and SPRY domain containing, transcript variant X1
B-box and SPRY domain containing, transcript variant X2
B box and SPRY domain-containing protein isoform X1
B box and SPRY domain-containing protein isoform X2
haloacid dehalogenase like hydrolase domain containing 3, transcript variant X1
haloacid dehalogenase like hydrolase domain containing 3, transcript variant X2
haloacid dehalogenase-like hydrolase domain-containing protein 3
aminolevulinate dehydratase, transcript variant X1
aminolevulinate dehydratase, transcript variant X2
aminolevulinate dehydratase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
DNA polymerase epsilon 3, accessory subunit
chromosome 30 C9orf43 homolog, transcript variant X1
chromosome 30 C9orf43 homolog, transcript variant X4
chromosome 30 C9orf43 homolog, transcript variant X5
chromosome 30 C9orf43 homolog, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
chromosome 30 C9orf43 homolog, transcript variant X3
chromosome 30 C9orf43 homolog, transcript variant X2
uncharacterized protein C9orf43 homolog isoform X1
uncharacterized protein C9orf43 homolog isoform X2
uncharacterized protein C9orf43 homolog isoform X3
uncharacterized protein C9orf43 homolog isoform X4
regulator of G protein signaling 3, transcript variant X4
regulator of G protein signaling 3, transcript variant X1
regulator of G-protein signaling 3 isoform X1
regulator of G-protein signaling 3 isoform X4
regulator of G protein signaling 3, transcript variant X7
regulator of G protein signaling 3, transcript variant X2
regulator of G protein signaling 3, transcript variant X3
regulator of G-protein signaling 3 isoform X2
regulator of G-protein signaling 3 isoform X3
regulator of G-protein signaling 3 isoform X6
regulator of G protein signaling 3, transcript variant X5
regulator of G protein signaling 3, transcript variant X6
regulator of G-protein signaling 3 isoform X5
regulator of G protein signaling 3, transcript variant X8
regulator of G protein signaling 3, transcript variant X9
regulator of G-protein signaling 3 isoform X7
regulator of G-protein signaling 3 isoform X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
zinc finger protein 618, transcript variant X1
zinc finger protein 618, transcript variant X4
zinc finger protein 618, transcript variant X2
zinc finger protein 618, transcript variant X5
zinc finger protein 618, transcript variant X11
zinc finger protein 618, transcript variant X13
zinc finger protein 618, transcript variant X12
zinc finger protein 618, transcript variant X14
zinc finger protein 618, transcript variant X17
zinc finger protein 618, transcript variant X6
zinc finger protein 618, transcript variant X8
zinc finger protein 618, transcript variant X15
zinc finger protein 618, transcript variant X16
zinc finger protein 618, transcript variant X18
zinc finger protein 618, transcript variant X3
zinc finger protein 618, transcript variant X7
zinc finger protein 618, transcript variant X9
zinc finger protein 618, transcript variant X10
kinesin family member 12, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
kinesin family member 12, transcript variant X3
kinesin family member 12, transcript variant X1
kinesin family member 12, transcript variant X2
kinesin family member 12, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
kinesin family member 12, transcript variant X5
collagen type XXVII alpha 1 chain, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
collagen type XXVII alpha 1 chain, transcript variant X1
collagen type XXVII alpha 1 chain, transcript variant X6
collagen type XXVII alpha 1 chain, transcript variant X5
collagen type XXVII alpha 1 chain, transcript variant X3
collagen alpha-1(XXVII) chain isoform X1
collagen alpha-1(XXVII) chain isoform X6
collagen alpha-1(XXVII) chain isoform X5
collagen alpha-1(XXVII) chain isoform X3
collagen type XXVII alpha 1 chain, transcript variant X2
collagen alpha-1(XXVII) chain isoform X2
collagen type XXVII alpha 1 chain, transcript variant X4
collagen alpha-1(XXVII) chain isoform X4
AT-hook transcription factor, transcript variant X4
AT-hook transcription factor, transcript variant X3
AT-hook transcription factor, transcript variant X2
AT-hook transcription factor, transcript variant X5
AT-hook transcription factor, transcript variant X1
microtubule organization protein AKNA isoform X2
microtubule organization protein AKNA isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 4 ESTs, 9 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 74% coverage of the annotated genomic feature by RNAseq alignments
transmembrane protein 268, transcript variant X1
transmembrane protein 268, transcript variant X2
transmembrane protein 268, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
transmembrane protein 268, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 1 Protein, and 38% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00614
tumor necrosis factor ligand superfamily member 15
tumor necrosis factor ligand superfamily member 8
uncharacterized LOC122431750, transcript variant X4
uncharacterized LOC122431750, transcript variant X5
uncharacterized LOC122431750, transcript variant X3
uncharacterized LOC122431750, transcript variant X1
uncharacterized LOC122431750, transcript variant X2
10 kDa heat shock protein, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 66% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
tripartite motif containing 32, transcript variant X3
tripartite motif containing 32, transcript variant X5
tripartite motif containing 32, transcript variant X7
tripartite motif containing 32, transcript variant X1
tripartite motif containing 32, transcript variant X6
tripartite motif containing 32, transcript variant X2
tripartite motif containing 32, transcript variant X8
tripartite motif containing 32, transcript variant X4
tripartite motif containing 32, transcript variant X9
tripartite motif containing 32, transcript variant X10
telomere length and silencing protein 1 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
BMP/retinoic acid inducible neural specific 1
BMP/retinoic acid-inducible neural-specific protein 1
CDK5 regulatory subunit associated protein 2, transcript variant X5
CDK5 regulatory subunit associated protein 2, transcript variant X6
CDK5 regulatory subunit associated protein 2, transcript variant X7
CDK5 regulatory subunit associated protein 2, transcript variant X8
CDK5 regulatory subunit associated protein 2, transcript variant X1
CDK5 regulatory subunit associated protein 2, transcript variant X3
CDK5 regulatory subunit associated protein 2, transcript variant X2
CDK5 regulatory subunit-associated protein 2 isoform X5
CDK5 regulatory subunit-associated protein 2 isoform X6
CDK5 regulatory subunit-associated protein 2 isoform X7
CDK5 regulatory subunit-associated protein 2 isoform X1
CDK5 regulatory subunit-associated protein 2 isoform X2
CDK5 regulatory subunit-associated protein 2 isoform X8
CDK5 regulatory subunit-associated protein 2 isoform X3
CDK5 regulatory subunit associated protein 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 39 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
CDK5 regulatory subunit-associated protein 2 isoform X4
multiple epidermal growth factor-like domains protein 9
beta-1,3-galactosyltransferase 9, transcript variant X1
beta-1,3-galactosyltransferase 9, transcript variant X4
beta-1,3-galactosyltransferase 9, transcript variant X3
beta-1,3-galactosyltransferase 9, transcript variant X5
F-box and WD repeat domain containing 2, transcript variant X4
F-box and WD repeat domain containing 2, transcript variant X2
F-box and WD repeat domain containing 2, transcript variant X1
F-box and WD repeat domain containing 2, transcript variant X3
F-box/WD repeat-containing protein 2 isoform X3
F-box/WD repeat-containing protein 2 isoform X1
F-box/WD repeat-containing protein 2 isoform X2
F-box/WD repeat-containing protein 2 isoform X4
beta-1,3-galactosyltransferase 9, transcript variant X2
26S proteasome non-ATPase regulatory subunit 5
protein CutA homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
protein CutA homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
PHD finger protein 19, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 mRNAs, 11 ESTs, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
PHD finger protein 19, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 11 ESTs, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
uncharacterized LOC122431901, transcript variant X2
uncharacterized LOC122431901, transcript variant X1
TNF receptor associated factor 1, transcript variant X8
TNF receptor associated factor 1, transcript variant X3
TNF receptor associated factor 1, transcript variant X6
TNF receptor associated factor 1, transcript variant X1
TNF receptor associated factor 1, transcript variant X4
TNF receptor associated factor 1, transcript variant X2
TNF receptor associated factor 1, transcript variant X5
TNF receptor-associated factor 1 isoform X1
TNF receptor-associated factor 1 isoform X3
TNF receptor associated factor 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
TNF receptor-associated factor 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 4% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 11 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 13 ESTs, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
transfer RNA arginine (anticodon ACG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
doublecortin domain-containing protein 2C
1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase
trafficking protein particle complex subunit 12, transcript variant X2
trafficking protein particle complex subunit 12, transcript variant X1
trafficking protein particle complex subunit 12 isoform X2
trafficking protein particle complex subunit 12 isoform X1
EARP complex and GARP complex interacting protein 1, transcript variant X1
EARP and GARP complex-interacting protein 1 isoform X1
EARP complex and GARP complex interacting protein 1, transcript variant X3
EARP complex and GARP complex interacting protein 1, transcript variant X4
EARP complex and GARP complex interacting protein 1, transcript variant X2
EARP and GARP complex-interacting protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 29 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
EARP and GARP complex-interacting protein 1 isoform X3
myelin transcription factor 1 like, transcript variant X1
myelin transcription factor 1 like, transcript variant X7
myelin transcription factor 1 like, transcript variant X4
myelin transcription factor 1 like, transcript variant X3
myelin transcription factor 1 like, transcript variant X5
myelin transcription factor 1 like, transcript variant X9
myelin transcription factor 1 like, transcript variant X6
myelin transcription factor 1 like, transcript variant X10
myelin transcription factor 1 like, transcript variant X8
myelin transcription factor 1 like, transcript variant X2
myelin transcription factor 1 like, transcript variant X24
myelin transcription factor 1 like, transcript variant X23
myelin transcription factor 1 like, transcript variant X11
myelin transcription factor 1 like, transcript variant X13
myelin transcription factor 1 like, transcript variant X20
myelin transcription factor 1 like, transcript variant X21
myelin transcription factor 1 like, transcript variant X22
myelin transcription factor 1-like protein isoform X1
myelin transcription factor 1-like protein isoform X7
myelin transcription factor 1-like protein isoform X3
myelin transcription factor 1-like protein isoform X5
myelin transcription factor 1-like protein isoform X9
myelin transcription factor 1-like protein isoform X6
myelin transcription factor 1-like protein isoform X10
myelin transcription factor 1-like protein isoform X8
myelin transcription factor 1-like protein isoform X2
myelin transcription factor 1-like protein isoform X16
myelin transcription factor 1-like protein isoform X11
myelin transcription factor 1-like protein isoform X4
myelin transcription factor 1-like protein isoform X15
myelin transcription factor 1-like protein isoform X13
myelin transcription factor 1-like protein isoform X14
myelin transcription factor 1 like, transcript variant X18
myelin transcription factor 1 like, transcript variant X15
myelin transcription factor 1 like, transcript variant X14
myelin transcription factor 1 like, transcript variant X19
myelin transcription factor 1 like, transcript variant X17
myelin transcription factor 1 like, transcript variant X16
myelin transcription factor 1 like, transcript variant X12
myelin transcription factor 1-like protein isoform X12
thyroid peroxidase, transcript variant X2
thyroid peroxidase, transcript variant X1
syntrophin gamma 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
syntrophin gamma 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
syntrophin gamma 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
syntrophin gamma 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
transmembrane protein 18, transcript variant X1
transmembrane protein 18, transcript variant X2
uncharacterized LOC122431976, transcript variant X1
uncharacterized LOC122431976, transcript variant X2
acid phosphatase 1, transcript variant X3
acid phosphatase 1, transcript variant X1
low molecular weight phosphotyrosine protein phosphatase isoform X1
low molecular weight phosphotyrosine protein phosphatase isoform X2
acid phosphatase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
SH3 and SYLF domain containing 1, transcript variant X6
SH3 and SYLF domain containing 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 3 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
SH3 domain-containing YSC84-like protein 1 isoform X2
SH3 and SYLF domain containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 3 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
SH3 and SYLF domain containing 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 2 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
SH3 and SYLF domain containing 1, transcript variant X5
SH3 domain-containing YSC84-like protein 1 isoform X1
SH3 domain-containing YSC84-like protein 1 isoform X3
SH3 and SYLF domain containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 3 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
SH3 and SYLF domain containing 1, transcript variant X4
family with sequence similarity 110 member C, transcript variant X1
family with sequence similarity 110 member C, transcript variant X2